Literature DB >> 2029987

Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat.

P D Hall1, J L Plummer, A H Ilsley, M J Cousins.   

Abstract

Rats were exposed to carbon tetrachloride vapor, 5 days/wk, 6 hr/day, for periods of 5 or 10 wk at a concentration that by itself caused only fatty change with minimal liver cell necrosis and no fibrosis. The same carbon tetrachloride exposure when given in association with chronic alcohol feeding resulted in extensive hepatic fibrosis at 5 wk and established micronodular cirrhosis at 10 wk. The periodicity of the exposure profile was chosen to simulate that of human exposure to environmental toxins, albeit at a higher dose than would be permitted in the workplace. The development of significant liver injury in this animal model raises the possibility that some chronic liver injury in humans may be due to alcohol potentiation of other hepatotoxins present in the environment at subtoxic levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029987     DOI: 10.1016/0270-9139(91)90246-r

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.

Authors:  Jessica I Cohen; Laura E Nagy
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

2.  P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice.

Authors:  Saurabh Chatterjee; Ritu Rana; Jean Corbett; Maria B Kadiiska; Joyce Goldstein; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2012-02-15       Impact factor: 7.376

Review 3.  Rodent models of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

Review 4.  Animal models of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-03       Impact factor: 5.187

Review 5.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

6.  Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats.

Authors:  Andréia S Lessa; Bruno D Paredes; Juliana V Dias; Adriana B Carvalho; Luiz Fernando Quintanilha; Christina M Takiya; Bernardo R Tura; Guilherme F M Rezende; Antonio C Campos de Carvalho; Célia M C Resende; Regina C S Goldenberg
Journal:  BMC Vet Res       Date:  2010-01-29       Impact factor: 2.741

7.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

Review 8.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

Review 9.  "Second hit" models of alcoholic liver disease.

Authors:  Hidekazu Tsukamoto; Keigo Machida; Alla Dynnyk; Hasmik Mkrtchyan
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

10.  Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.

Authors:  Yue-Min Nan; Ling-Bo Kong; Wei-Guang Ren; Rong-Qi Wang; Jing-Hua Du; Wen-Cong Li; Su-Xian Zhao; Yu-Guo Zhang; Wen-Juan Wu; Hai-Ling Di; Ya Li; Jun Yu
Journal:  Lipids Health Dis       Date:  2013-02-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.